Back
PANEL DISCUSSION: Designing the Next Generation of Rare Disease Therapies: From Advanced Genomics to AI-Enabled Therapeutic Innovation
Wednesday, January 27, 2027 at 12:30 PM to 1:00 PM · 30 min. (Europe/London)
Advanced Therapies Stage
Day 1 - Wednesday 27th January
Advanced Therapies
AI
Precision Medicine
Information
How is our growing understanding of disease genetics changing the way therapies for rare diseases are designed and developed?
What role can AI play in therapeutic design and the development of next-generation treatments for rare diseases?
What are the biggest challenges in translating innovative genome-based therapies from discovery into safe, effective and scalable clinical treatments?
How can the industry accelerate the development of more precise and potentially personalised therapies for rare diseases?
Speakers
Dan O'Connor
Director, Regulatory Policy & Early Access
ABPI
Deborah Richards
VP & General Manager, UK & Ireland
Alexion, AstraZeneca Rare Disease
Tassos Georgiadis
SVP Discovery & Preclinical Development
MeiraGTx
Killian Hanlon
CEO & Chief Scientist
Lir Therapeutics